Forecast

There is no analyst data available for this company.

News Go to news feed

Vext Science increases margins and EBITDA in Q2 2026 despite revenue decline

Vext Science reported Q2 2026 revenue of $12.1 million (‑10% year on year), with a significantly higher gross margin of 55% and adjusted EBITDA of $3.4 million. Net loss fell to $0.3 million and gross profit rose to $6.7 million, supported by a stronger retail mix and better harvest yields in Ohio. The company is reducing cultivation in Arizona in favor of purchases and continues to focus on growth in Ohio, debt reduction and inventory conversion. The stock reacted positively, rising to $0.28; analysts expect profitability for the year. » More on de.investing.com
Vext Science reports Q3 revenue jump of 41% to 12.7 million USD

Vext Science increased revenue in the third quarter of 2025 by 41% to 12.7 million USD and recorded adjusted EBITDA of 2.1 million USD (margin 16.7%). The growth is attributed to expansions in Ohio and operational efficiency improvements in Arizona; the company plans eight dispensing locations in Ohio by 2026. Operating cash flow was 1.26 million USD, cash on hand stood at 3.7 million USD, and the stock rose 6.25% after the results. Vext Science expects improvements in revenue, adjusted EBITDA and cash flow for Q4, but sees risks from market saturation in Arizona and cross-regional price pressure. » More on de.investing.com
Vext Science increases revenue in Q2 2025 by 59%, stock falls despite strong results

Vext Science Inc. reported Q2 2025 revenue of $13.4 million (up 59% year-on-year) and adjusted EBITDA of $4.1 million, driven by expansion of retail locations in Ohio and improved cost ratios. Despite the positive metrics, the stock fell 1.92%, reflecting investor concerns over high net debt and weaker markets in Arizona. » More on de.investing.com

Financials

In the last quarter, Vext Science had revenue of 10.35m€ and net profit of −268.88k€

(EUR)	Jun 2026	YoY
Revenue	+10.35m	9,03%
Gross profit	+1.54m	62,64%
Net profit	−268.88k	78,56%
EBITDA	+1.90m	57,86%

Fundamentals

Metric	Value
Market capitalization	+44.49m€
Number of shares	247.68m
52-week high/low	+0,25€ - +0,12€
Dividends	No
Beta	0,8
P/E ratio	−2,88
PEG ratio	−0,49
P/B ratio	+0,96
P/S ratio	+1,03

Company profile

Vext Science, Inc. ist über seine Tochtergesellschaften als integriertes Unternehmen für Agrartechnologie, Dienstleistungen und Immobilienverwaltung in der Cannabisbranche in den Vereinigten Staaten tätig. Das Unternehmen befasst sich mit dem Anbau, der Extraktion, der Herstellung und dem Verkauf von THC- und CBD-Patronen, Konzentraten und Esswaren. Darüber hinaus ist das Unternehmen im Einzelhandel und im Großhandel mit THC- und CBD-Produkten aus Cannabis und Hanf unter den Marken Vapen und Pure Touch Botanicals tätig. Darüber hinaus bietet das Unternehmen unter der Marke Vapen Kitchens Vapen Clear Infused Products, THC-Schokoriegel, THC-Sirup, THC-Snacks, Bonbons und Gummibärchen an. Das Unternehmen war früher als Vapen MJ Ventures Corporation bekannt und änderte im November 2019 seinen Namen in Vext Science, Inc. Vext Science, Inc. wurde im Jahr 2015 gegründet und hat seinen Hauptsitz in Phoenix, Arizona.